The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Authors
Keywords
Thiazolidinedione, Peroxisomal proliferator-activated receptor-γ, Pioglitazone, Rosiglitazone, Type 2 diabetes mellitus, Insulin resistance, Dyslipidemia, Nonalcoholic fatty liver disease, Nonalcoholic steatoh epatitis, Polycystic ovarian syndrome
Journal
Current Diabetes Reports
Volume 13, Issue 3, Pages 329-341
Publisher
Springer Nature
Online
2013-05-01
DOI
10.1007/s11892-013-0378-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control: The Rotterdam Study
- (2013) L. Oei et al. DIABETES CARE
- Is There a Role for Laparoscopic Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma? A Critical Appraisal of the Literature
- (2013) C. Jurowich et al. HORMONE AND METABOLIC RESEARCH
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation
- (2012) Lichu Liu et al. CALCIFIED TISSUE INTERNATIONAL
- Risk of Fracture with Thiazolidinediones: Disease or Drugs?
- (2012) Marloes T. Bazelier et al. CALCIFIED TISSUE INTERNATIONAL
- A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
- (2012) Michael J. Pishvaian et al. CANCER
- Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
- (2012) Dawn M. Torres et al. Clinical Gastroenterology and Hepatology
- Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
- (2012) M. -Y. Li et al. CURRENT CANCER DRUG TARGETS
- A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome
- (2012) Qiang Du et al. CURRENT MEDICAL RESEARCH AND OPINION
- Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
- (2012) I.N. Colmers et al. DIABETES & METABOLISM
- Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry
- (2012) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism
- (2012) Aleksandra Mieczkowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
- (2012) Chin-Hsiao Tseng JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
- (2012) Marloes T. Bazelier et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes
- (2012) George R. Beck et al. Translational Research
- The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
- (2012) Sun Ok Song et al. Diabetes & Metabolism Journal
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
- (2011) Shih-Wei Lai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
- (2011) X.- X. He et al. ANNALS OF ONCOLOGY
- Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells
- (2011) Myoung Woo Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
- (2011) Kim Henriksen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- (2011) Romina Lomonaco et al. HEPATOLOGY
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- (2011) Chia-Hsuin Chang et al. HEPATOLOGY
- Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
- (2011) B. Walter et al. MEDICAL ONCOLOGY
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL
- (2011) Marie-Laure Plissonnier et al. PLoS One
- Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
- (2011) Maria Vinaixa et al. PLoS One
- Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis
- (2010) X-J. Li et al. CLINICAL ENDOCRINOLOGY
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals
- (2010) A. Zanchi et al. DIABETOLOGIA
- Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study
- (2010) Katerina K. Naka et al. FERTILITY AND STERILITY
- Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months
- (2010) Lourdes Ibáñez et al. GYNECOLOGICAL ENDOCRINOLOGY
- Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
- (2010) Vlad Ratziu et al. HEPATOLOGY
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes
- (2010) Matthias Herz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
- (2010) Bernard Charbonnel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate
- (2009) K. K. Roy et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study
- (2009) C. Hohberg et al. DIABETES OBESITY & METABOLISM
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- (2009) OBSTETRICS AND GYNECOLOGY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Rapid improvement of carotid plaque echogenicity within 1 month of pioglitazone treatment in patients with acute coronary syndrome
- (2008) Mitsumasa Hirano et al. ATHEROSCLEROSIS
- Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone
- (2008) Issa J Dahabreh Clinical Trials
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes
- (2008) Takashi Okamoto et al. Geriatrics & Gerontology International
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
- (2008) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for the Treatment of the Polycystic Ovary Syndrome
- (2008) John E. Nestler NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now